Malcontenti-Wilson C - Search Results

1

The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo.

Burns CJ, Fantino E, Powell AK, Shnyder SD, Cooper PA, Nelson S, Christophi C, Malcontenti-Wilson C, Dubljevic V, Harte MF, Joffe M, Phillips ID, Segal D, Wilks AF, Smith GD. Burns CJ, et al. Among authors: malcontenti wilson c. J Pharmacol Exp Ther. 2011 Dec;339(3):799-806. doi: 10.1124/jpet.111.186965. Epub 2011 Sep 14. J Pharmacol Exp Ther. 2011. PMID: 21917561

2

CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivo.

Burns CJ, Fantino E, Phillips ID, Su S, Harte MF, Bukczynska PE, Frazzetto M, Joffe M, Kruszelnicki I, Wang B, Wang Y, Wilson N, Dilley RJ, Wan SS, Charman SA, Shackleford DM, Fida R, Malcontenti-Wilson C, Wilks AF. Burns CJ, et al. Mol Cancer Ther. 2009 Nov;8(11):3036-45. doi: 10.1158/1535-7163.MCT-09-0076. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887548

3

Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.

Chan LS, Malcontenti-Wilson C, Muralidharan V, Christophi C. Chan LS, et al. Anticancer Res. 2007 Jul-Aug;27(4B):2317-23. Anticancer Res. 2007. PMID: 17695520 Free article.

4

Scanning electron microscopy study of the blood supply of human colorectal liver metastases.

Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, Christophi C. Nikfarjam M, et al. Eur J Surg Oncol. 2003 Dec;29(10):856-61. doi: 10.1016/j.ejso.2003.08.009. Eur J Surg Oncol. 2003. PMID: 14624778

5

Alterations in vascular architecture and permeability following OXi4503 treatment.

Chan LS, Malcontenti-Wilson C, Muralidharan V, Christophi C. Chan LS, et al. Anticancer Drugs. 2008 Jan;19(1):17-22. doi: 10.1097/CAD.0b013e3282f077a1. Anticancer Drugs. 2008. PMID: 18043126

6

Lymphatic patterns of colorectal liver metastases.

Hadj AK, Malcontenti-Wilson C, Nikfarjam M, Christophi C. Hadj AK, et al. J Surg Res. 2012 Apr;173(2):292-8. doi: 10.1016/j.jss.2010.09.012. Epub 2010 Oct 8. J Surg Res. 2012. PMID: 21035136

7

Interstitial laser hyperthermia and the biological characteristics of tumor: study in a murine model of colorectal liver metastases.

Muralidharan V, Nikfarjam M, Malcontenti-Wilson C, Christophi C. Muralidharan V, et al. J Clin Laser Med Surg. 2003 Apr;21(2):75-83. doi: 10.1089/104454703765035493. J Clin Laser Med Surg. 2003. PMID: 12737647

8

P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth.

He H, Huynh N, Liu KH, Malcontenti-Wilson C, Zhu J, Christophi C, Shulkes A, Baldwin GS. He H, et al. Among authors: malcontenti wilson c. Cancer Lett. 2012 Apr 1;317(1):65-71. doi: 10.1016/j.canlet.2011.11.014. Epub 2011 Nov 15. Cancer Lett. 2012. PMID: 22100495

9

Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.

Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C. Neo JH, et al. J Gastroenterol Hepatol. 2007 Apr;22(4):577-84. doi: 10.1111/j.1440-1746.2006.04797.x. J Gastroenterol Hepatol. 2007. PMID: 17376054

10

Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model.

Malcontenti-Wilson C, Muralidharan V, Skinner S, Christophi C, Sherris D, O'Brien PE. Malcontenti-Wilson C, et al. Clin Cancer Res. 2001 Apr;7(4):1052-60. Clin Cancer Res. 2001. PMID: 11309357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters